TLSI

TriSalus Life Sciences, Inc.

Sales chart range
Log in to watch TLSI
Latest sale
$1k
May 15 · No plan
Form 4 sales
13
On record
Form 144 notices
1
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleNo plan
    May 19 2025

    Sold 4,764 shares at $5.18 ($25k)

    Devlin Jodi, Chief of Clinical Operations

    No 10b5-1 planSold 8.3% of holdings ($298k position)52,764 shares leftFirst sale on recordFiling

  2. 2 Form 4 saleNo plan
    May 19 same day

    Sold 4,764 shares at $5.18 ($25k)

    Cox Bryan F., Chief of Research

    No 10b5-1 planSold 3.8% of holdings ($643k position)119,415 shares leftFiling

  3. 3 Form 4 saleNo plan
    Mar 16 +301 days

    Sold 3,530 shares at $4.11 ($15k)

    Stevens Jennifer, Chief Regulatory Officer

    No 10b5-1 planSold 2.8% of holdings ($525k position)124,110 shares leftFiling

  4. 4 Form 4 saleNo plan
    Mar 16 same day

    Sold 3,457 shares at $4.11 ($14k)

    Marshak Richard, Chief Commercial Officer

    No 10b5-1 planSold 3% of holdings ($468k position)110,397 shares leftFiling

  5. 5 Form 4 saleNo plan
    Mar 16 same day

    Sold 3,184 shares at $4.11 ($13k)

    Cox Bryan F., Chief of Research

    No 10b5-1 planSold 1.9% of holdings ($685k position)163,415 shares leftFiling

  6. 6 Form 4 saleNo plan
    Mar 16 same day

    Sold 3,207 shares at $4.11 ($13k)

    Devlin Jodi, Chief of Clinical Operations

    No 10b5-1 planSold 3.2% of holdings ($413k position)97,364 shares leftFiling

  7. 7 Form 4 saleNo plan
    Mar 17 +1 day

    Sold 20,302 shares at $3.91 ($79k)

    Szela Mary T, CEO and President

    No 10b5-1 planSold 2.6% of holdings ($3M position)752,987 shares leftFirst sale on recordFiling

  8. 8 Form 4 saleNo plan
    May 15 +59 days

    Sold 543 shares at $2.67 ($1k)

    Marshak Richard, Chief Commercial Officer

    No 10b5-1 planSold 0.4% of holdings ($335k position)125,101 shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (14)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for TLSI
Source
May 15, 2026Marshak RichardChief Commercial OfficerForm 4 sale543$1k0.4%No planSEC
Mar 17, 2026Szela Mary TCEO and PresidentForm 4 sale20,302$79k2.6%No planSEC
Mar 16, 2026Devlin JodiChief of Clinical OperationsForm 4 sale3,207$13k3.2%No planSEC
Mar 16, 2026Cox Bryan F.Chief of ResearchForm 4 sale3,184$13k1.9%No planSEC
Mar 16, 2026Marshak RichardChief Commercial OfficerForm 4 sale3,457$14k3.0%No planSEC
Mar 16, 2026Stevens JenniferChief Regulatory OfficerForm 4 sale3,530$15k2.8%No planSEC
May 19, 2025Cox Bryan F.Chief of ResearchForm 4 sale4,764$25k3.8%No planSEC
May 19, 2025Devlin JodiChief of Clinical OperationsForm 4 sale4,764$25k8.3%No planSEC
May 19, 2025Marshak RichardChief Commercial OfficerForm 4 sale6,597$34k8.7%No planSEC
May 19, 2025Stevens JenniferChief Regulatory OfficerForm 4 sale8,704$45k10.1%No planSEC
Dec 10, 2024Desai Arjun JJDirectorForm 4 sale30,000$111k10.8%No planSEC
Dec 10, 2024Desai Arjun JJBoard of DirectorsForm 144 notice30,000$135kNoticeSEC
Oct 5, 2024Cox Bryan F.CHIEF SCIENTIFIC & MANUFACT.Form 4 sale314$1k0.4%No planSEC
Aug 28, 2024Martin George KellyDirectorForm 4 sale9$500.0%No planSEC